These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 16539730
21. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer. Patel K, Whelan PJ, Prescott S, Brownhill SC, Johnston CF, Selby PJ, Burchill SA. Clin Cancer Res; 2004 Nov 15; 10(22):7511-9. PubMed ID: 15569981 [Abstract] [Full Text] [Related]
22. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]. Liu BQ, Wu YD, Wei JX, Zhang T, Liu RL, Ma TX. Zhonghua Nan Ke Xue; 2007 Nov 15; 13(11):997-1001. PubMed ID: 18077911 [Abstract] [Full Text] [Related]
24. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma. Lin VK, Wang SY, Boetticher NC, Vazquez DV, Saboorian H, McConnell JD, Roehrborn CG. Prostate; 2005 May 15; 63(3):299-308. PubMed ID: 15611997 [Abstract] [Full Text] [Related]
25. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions. Zielie PJ, Mobley JA, Ebb RG, Jiang Z, Blute RD, Ho SM. J Urol; 2004 Sep 15; 172(3):1130-3. PubMed ID: 15311056 [Abstract] [Full Text] [Related]
26. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy. Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G. Urology; 2007 Dec 15; 70(6):1225-9. PubMed ID: 18158066 [Abstract] [Full Text] [Related]
27. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Soulitzis N, Karyotis I, Delakas D, Spandidos DA. Int J Oncol; 2006 Aug 15; 29(2):305-14. PubMed ID: 16820871 [Abstract] [Full Text] [Related]
35. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Wang J, Weng J, Cai Y, Penland R, Liu M, Ittmann M. Prostate; 2006 Jun 01; 66(8):847-57. PubMed ID: 16491480 [Abstract] [Full Text] [Related]
36. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue. Lintula S, Stenman J, Bjartell A, Nordling S, Stenman UH. Prostate; 2005 Jun 01; 63(4):324-9. PubMed ID: 15599939 [Abstract] [Full Text] [Related]
37. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer]. Weng ZL, Yu KY, Mao XL, Tao ZH, Chen XD, Wu XL, Hu YP, Wang SQ, Li CD, Chen ZG. Zhonghua Yi Xue Za Zhi; 2006 Nov 07; 86(41):2911-5. PubMed ID: 17288789 [Abstract] [Full Text] [Related]
38. CCR2 expression correlates with prostate cancer progression. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J. J Cell Biochem; 2007 Jun 01; 101(3):676-85. PubMed ID: 17216598 [Abstract] [Full Text] [Related]